Selected Publications

McCarthy BE, McClelland RL, Appleby DH, Moutchia JS, Minhas JK, Min J, Mazurek JA, Smith KA, Fritz JS, Pugliese SC, Urbanowicz RJ, Holmes JH, Palevsky HI, Kawut SM, Al-Naamani N.: BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis Chest 162 (2): 436-447,2022.

Matura LA, Fargo JD, Boyle K, Fritz JS, Smith KA, Mazurek JA, Pinder D, Archer-Chicko CL, Palevsky HI, Pack AI, Sommers MS, Kawut SM: Symptom phenotypes in pulmonary arterial hypertension: The PAH "symptome" Pulm Circ 12 (3): e12135 published on-line,2022.

Min J, Appleby DH, McClelland RL, Minhas J, Holmes JH, Urbanowicz RJ, Pugliese SC, Mazurek JA, Smith KA, Fritz JS, Palevsky HI, Suh JM, Al-Naamani N, Kawut SM.: Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants Ann Am Thorac Soc 19 (6): 952-961,2022.

Goodman R, Chirinos JA, Ky B, Mazurek JA, Smith KA, Palevsky HI, Fritz JS, Pugliese SC, Kawut SM, Al-Naamani N.: Systemic arterial properties in pulmonary hypertension. Pulm Circ. 11 (4): 1-3 published on-line,2021.

Sun W, Tang Y, Tai YY, Handen A, Zhao J, Speyer G, Al Aaraj Y, Watson A, Romanelli ME, Sembrat J, Rojas M, Simon MA, Zhang Y, Lee J, Xiong Z, Dutta P, Vasamsetti SB, McNamara D, McVerry B, McTiernan CF, Sciurba FC, Kim S, Smith KA, Mazurek JA, Han Y, Vaidya A, Nouraie SM, Kelly NJ, Chan SY.: SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension. JACC Basic Transl Sci 5 (11): 1073-1092,2020.

Kawut SM, Pinder D, Al-Naamani N, McCormick A, Palevsky HI, Fritz J, Smith KA, Mazurek JA, Doyle MF, MacLean MR, DeMichele A, Mankoff DA: Fulvestrant for the Treatment of Pulmonary Arterial Hypertension. Ann Am Thorac Soc 16 (11): 1456-1459,2019.

Estephan LE, Genuardi MV, Kosanovich CM, Risbano MG1, Zhang Y, Petro N, Watson A, Al Aaraj Y, Sembrat JC1, Rojas M, Goncharov DA, Simon MA, Goncharova EA, Vaidya A, Smith A, Mazurek J, Han Y, Chan SY.: Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertension Pulmonary Circulation 9 (2): 2019.

Bhattacharya PT, Troutman GS, Mao F, Fox AL, Tanna MS, Zamani P, Grandin EW, Menachem JN, Birati EY, Chirinos JA, Mazimba S, Smith KA, Kawut SM, Forfia PR, Vaidya A, Mazurek JA: Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension Pulmonary Circulation 9 (2): 784-795,2019.

Goodman R, Ky B, Narasimhan V, Mazurek JA, Smith KA, Palevsky HI, Fritz JS, Archer-Chicko CL, Patel M, Pinder D, Boyle K, Pugliese S, Burwell C, Chirinos JA, Kawut SM, Al-Naamani N.: The association of systemic vascular properties with right ventricular function in patients with pulmonary hypertension. American Thoracic Society International Conference, May 2019. : 2019.

Bhardwaj, A., Al-Naamani, N., Pinder, D., Boyle, K., McCormick, A., Patel, M., Burwell, C.A., Smith, A., Mazurek, J.A., Archer-Chicko, C.L., Palevsky, H.I., Fritz, J.S., Pugliese, S., Kawut, S. M.: Changing demographics of patients with idiopathic pulmonary arterial hypertension (IPAH). American Thoracic Society International Conference, Dallas, TX : 2019.

Academic Contact Information

Pulmonary, Allergy and Critical Care Division
Perelman School of Medicine, University of Pennsylvania
834 West Gates Building
3400 Spruce Street
Philadelphia, PA 19104
Phone: 215-662-3202
Patient appointments: 800-789-7366